Cargando…
An update on inhibitors targeting RNA-dependent RNA polymerase for COVID-19 treatment: Promises and challenges
The highly transmissible variants of SARS-CoV-2, the causative pathogen of the COVID-19 pandemic, bring new waves of infection worldwide. Identification of effective therapeutic drugs to combat the COVID-19 pandemic is an urgent global need. RNA-dependent RNA polymerase (RdRp), an essential enzyme f...
Autores principales: | Xu, Xiaoying, Chen, Yuheng, Lu, Xinyu, Zhang, Wanlin, Fang, Wenxiu, Yuan, Luping, Wang, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535928/ https://www.ncbi.nlm.nih.gov/pubmed/36209840 http://dx.doi.org/10.1016/j.bcp.2022.115279 |
Ejemplares similares
-
In silico identification of promising inhibitor against RNA-dependent RNA polymerase target of SARS-CoV-2
por: Singh, Pushpendra, et al.
Publicado: (2021) -
RNA‐dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID‐19
por: Machitani, Mitsuhiro, et al.
Publicado: (2020) -
DNA polymerases as chemotherapy targets: promise and challenges
por: Eckert, Kristin A., et al.
Publicado: (2019) -
Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target
por: Yashvardhini, Niti, et al.
Publicado: (2021) -
Inhibitors of Foot and Mouth Disease Virus Targeting a Novel Pocket of the RNA-Dependent RNA Polymerase
por: Durk, Ryan C., et al.
Publicado: (2010)